INVITED SPEAKER

“RNA interference therapy for preeclampsia”
Dr. Ananth Karumanchi (Cedars-Sinai Medical Center, USA)

“Future interaction among International Society of Hypertension (ISH), Japan Society of Hypertension (JSH) and ISSHP”
Dr. Hiroshi Itoh (Vice President of ISH (International Society of Hypertension), Immediate Past President of JSH (Japanese Society of Hypertension), Keio University School of Medicine, Japan)

“Pregnancy and kidney disease”
Dr. Naoki Kashihara (Kawasaki Medical School, Japan)

“Pre-eclampsia: a view of global issues and advances”
Dr. Peter von Dadelszen (King's College London, UK)

“Integrity and usefulness of research in pre-eclampsia”
Dr. Ben W. Mol (Monash University, Australia)

“Pre-eclampsia, syncytiotrophoblast stress and the ‘twilight placenta’”
Dr. Christopher WG Redman (University of Oxford, UK)

“COMT in the biology of preeclampsia”
Dr. Keizo Kanasaki (Shimane University, Japan)

“Trophoblast extracellular vesicles in preeclampsia”
Dr. Manu Vatish (University of Oxford, UK)

“Enhanced adenosine signaling in the placenta: a crucial pathogenic factor and a possible therapeutic target for preeclampsia”
Dr. Takayuki Iriyama (The University of Tokyo, Japan)

“The development of preeclampsia hypotheses in the last two decades: what has been disproved and what is still valid?”
Dr. Berthold Huppertz (Gottfried Schatz Research Center, Medical University of Graz, Austria)

“The role of autophagy in pathophysiology of PE”
Dr. Akitoshi Nakashima (University of Toyama, Japan)

“What is new n 2021 concerning late onset preeclampia (70-80% of preeclampsia cases): Maternal pre-pregnancy BMI”
Dr. Pierre-Yves Robillard (The University Hospital of Reunion, France)

“Long-term consequences of pregnancy complications: lessons from mouse models”
Dr. Torsten Plösch (Carl von Ossietzky University Oldenburg, Germany; and University of Groningen, The Netherlands)

“Adipokine / Lipokine and inflammatory process in preeclampsia”
Dr. Katsuhiko Naruse (Nara Medical University, Japan)

“Possible role of the NLRP3 inflammasome in preeclampsia”
Dr. Koumei Shirasuna (Tokyo University of Agriculture, Japan)

“Reliable urinary screening tests for preeclampsia”
Dr. Marco Scioscia (Mater Dei Hospital, Italy)

“Non-coding RNAs in extravillous trophoblast cells”
Dr. Toshihiro Takizawa (Nipppon Medical School, Japan)

“Expectant management of preeclampsia”
Dr. Eiji Kondoh (Komamoto University, Japan)

“Role of sFlt-1 on the development of preeclampsia: basic and clinical approach”
Dr. Hirotada Suzuki (Jichi Medical University, Japan)

“Temporary hypertension as well as white coat hypertension in the first trimester as risk factors for preeclampsia”
Dr. Chikako Hirashima (Jichi Medical University, Japan)

“Timing of delivery in late preterm pre-eclampsia”
Dr. Lucy Chappell (King's College London, UK)

“Simplified prediction criteria and management of preeclampsia for LMIC”
Dr. Sanjay Gupte (Secretary General World Gestosis Organization/Gupte Hospital and Centre for Research in Reproduction, India)

“Maternal mortality: how can lives are saved?”
Dr. Tomoaki Ikeda (Mie University Graduate School of Medicine, Japan)

“An update on current and emerging therapies to treat or prevent preeclampsia”
Dr. Stephen Tong (The University of Melbourne; and Mercy Perinatal, Mercy Hospital for Women, Australia)

“Statins for preeclampsia”
Dr. Keiichi Kumasawa (The University of Tokyo, Japan)

“Possible role of statin to prevent preeclampsia”
Dr. Muhammad Ilham Aldika Akbar (Universitas Airlangga, Indonesia)

“RCT: Pravastatin vs. placebo for prevention of term preeclampsia”
Dr. Moritz Dobert (Harris Birthright Research Centre for Fetal Medicine, King's College, UK)

“Timing of delivery and blood pressure cutoff for chronic hypertension during pregnancy before and after ACC/AHA 2017”
Dr. Giovanni Sisti (University of Arizona - Tucson, AZ, USA. Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine)

“Management of hypertensive disorders of pregnancy based on home blood pressure”
Dr. Hirohito Metoki (Tohoku Medical and Pharmaceutical University Faculty of Medicine, Japan)

“Trials of IT based-telemonitoring of blood pressure for pregnant women at higher risk: an overview of the BUMP trials”
Dr. Richard Mcmanus (University of Oxford, UK)

“Blood pressure after normal and pre-eclamptic pregnancy”
Dr. Mark A. Brown (St George Hospital, and University of NSW, Australia)

“Maternal diet and gut microbiota: effects on gut blood pressure and metabolism”
Dr. Marloes Dekker Nitert (The university of Queensland, Australia)

“Maternal immunological changes and the gut microbiome during pregnancy”
Dr. Marijke Faas (University Medical Center Groningen and University of Groningen, The Netherlands)

“The role of the microbiome in reproduction”
Dr. Sam Schoenmakers (Erasmus Medical Center Rotterdam, The Netherlands)

“Predicting and preventing long-term cardiovascular disease after preeclampsia”
Dr. Anne Cathrine Staff (University of Oslo, Norway)

“Hypertensive disorders of pregnancy and future maternal cardiovascular health”
Dr. Pensee Wu (Keele University, UK)

“Rheumatic diseases and HDP”
Dr. Atsuko Murashima (National Center for Child Health and Development (NCCHD), Japan)

“The role of exercise in the prevention of preeclampsia and gestational hypertension”
Dr. Margie Davenport (University of Alberta, Canada)

“The approaches and problems in the care of the postpartum women who suffered from hypertensive disorders of pregnancy”
Dr. Asako Mito (National Center for Child Health and Development (NCCHD), Japan)

“Differential diagnosis of pregnancy-associated thrombotic microangiopathies (TTP, aHUS, and HELLP syndrome)”
Dr. Masanori Matsumoto (Nara Medical University, Japan)

“Management of severe postpartum TMA”
Dr. Shintaro Makino (Juntendo University Urayasu Hospital, Japan)

“Complement Activation and Regulation in Preeclampsia and HELLP Syndrome”
Dr. Richard Burwick (Cedars-Sinai Medical Center, USA)

“Atypical Hemolytic Uremic Syndrome and Pregnancy”
Dr. Shoichi Maruyama (Nagoya University Graduate School of Medicine, Japan)

“The significance of proteinuria among pregnant women with preeclampsia”
Dr. Mamoru Morikawa (Kansai Medical University, Japan)

“Dysregulation of autotaxin-lysophosphatidic acid signaling system in preeclamptic placenta”
Dr. Takeshi Nagamatsu (The University of Tokyo, Japan)

“The importance of lifestyle interventions”
Dr. Satoko Nakamura (Kansai University of Welfare Sciences, Japan)

“A multicenter prospective study of home blood pressure measurement during pregnancy in Japanese women”
Dr. Kazushi Watanabe (Aichi Medical University School of Medicine, Japan)

“Proposal for a novel classification based on onset of HDP; antenatal onset, labor onset, and postpartum onset”
Dr. Yasumasa Ohno (Ohno Ladies Clinic, Japan)

“First 1000 days of life and non communicable diseases nexus”
Dr. Sanjay Gupte (Secretary General World Gestosis Organization/Gupte Hospital and Centre for Research in Reproduction, India)

“It all comes down to timing of delivery”
Dr. Alex C. Vidaeff (Texas Children's Hospital Pavilion for Women, USA)

“Prevention and prediction of preeclampsia”
Dr. Aris Antsaklis (University of Athens, Greece)

“Epidemiology of preeclampsia”
Dr. Panos Antsaklis (University of Athens, Greece)

“Gestosis score a practical tool to predict and risk stratify preeclampsia-gestosis”
Dr. Girija Wagh (Bharati Vidyapeeth University Medical College, India)

“General introduction to guidelines”
Dr. Laura Magee (King's College London, UK)

“Prediction and prevention of pre-eclampsia with aspirin”
Dr. Liona Poon (The Chinese University of Hong Kong, China)

“Biomarkers in suspected pre-eclampsia”
Dr. Sarosh Rana (The University of Chicago, USA)

“Prediction of adverse outcomes in pre-eclampsia”
Dr. Peter von Dadelszen (King's College London, UK)

“Antihypertensive therapy”
Dr. Laura Magee (King's College London, UK)

“The LMIC perspective”
Dr. David Hall (Department of Obstetrics and Gynaecology, Stellenbosch University and Tygerberg Hospital, South Africa)

“Use of ultrasound in modern obstetrics”
Dr. Liona Poon (The Chinese University of Hong Kong, China)

“The sFlt-1/PlGF-ratio to predict preeclampsia-related adverse outomces – clinical implementation”
Dr. Stefan Verlohren (Professor of Obstetrics,Consultant in Obstetrics and Maternal-Fetal Medicine, Department of Obstetrics)